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ta.2012.1Abstract Amplitude measurement and reproducibility of Transient-otoacoustic emissions
(T-EOAE) depend on synchronicity and functional integrity of cochlear outer hair cells, thus, the
main objective of this study was to determine the usefulness of amplitude measurement and repro-
ducibility in ﬁve selective frequencies of T-EOAE in patients with Sensorineural hearing loss
(SNHL). We studied 44 subjects with SNHL by means of T-EOAE and Brainstem auditory evoked
potentials (BAEP), and compared the results with those of a six control-normal-hearing subject
group. We observed signiﬁcant differences in the reproducibility of T-EOAE and in amplitudes
of 0.7, 1.5, 2.2, 3.0 and 3.7 kHz. In addition, we observed negative signiﬁcant correlations between
BAEP threshold and T-EOAE reproducibility and with all speciﬁc amplitude measurement
frequency values. These results conﬁrm the clinical usefulness of reproducibility and selective ampli-
tude measurement of frequency of T-EOAE for SNHL identiﬁcation.
ª 2013 Production and hosting by Elsevier on behalf of Egyptian Society of Ear, Nose, Throat and Allied
Sciences.1. Introduction
Hearing loss is the most prevalent sensory deﬁcit in humans.1
Frequency of hearing loss increases with age: 5% in adults
<45 years of age, and 60% in adults P70 years of age. Thetional Institute of Rehabilita-
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2.005most common type of hearing loss in adults is sensorineural.2
The majority of researchers have used a classic audiometric
test to search for Sensory-neural hearing loss (SNHL), but re-
cently new techniques such as High-frequency audiometry and
Threshold-equalizing-noise test, have been used for the early
detection of SNHL.3,4 Other audiologists have used
Otoacoustic emissions (OAE) to search for abnormal cochlear
function.5,6 Recently, high-frequency OAE has been used to
detect high-frequency SNHL.7 Some identiﬁed causes of
SNHL are treatable, but basically SNHL requires a laboratory
conﬁrmation, in the majority of cases it is difﬁcult to recognize
the etiology if the patient’s medical history and physical exam-
ination show normal results. Thus, we need better studies with
greater sensitivity to recognize subjects with SNHL as early as
possible.8ian Society of Ear, Nose, Throat and Allied Sciences.
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proceeding from the inner ear when this is stimulated with
acoustic transient tones.9,10 The diagnostic usefulness of
EOAE in audiology has proven the fact that only healthy co-
chlear systems are able to produce emissions, whereas nearly
every cochlear hearing loss leads to a decrease or disappear-
ance of EOAE.11,12 Since Kemp (1978) had ﬁrst described
Transient-EOAE (T-EOAE), the test has been used extensively
in pediatric and adult populations for clinical and research
applications.13,14 Among different types of EOAE; T-EOAE,
and Distortion products of EOAE (DP-EOAE) have received
particular attention, because they can be easily detected.14
EOAE can be modiﬁed by age and gender.15
T-EOAE, can provide important information concerning
the normal or abnormal condition of the Outer hair cells
(OHC); for example, these are the main targets of high-level
sound exposure 16 or ototoxic drug treatment.17–19 Indeed,
some researchers have suggested that T-EOAE may provide
earlier evidences of cochlear damage than Brainstem auditory
evoked potentials (BAEP).20 Their high test–retest reliability
coupled with their accuracy and objectivity in assessing co-
chlear function permits their use in monitoring dynamic
changes in cochlear responsiveness before these changes be-
come functionally signiﬁcant as a hearing loss. However, it
should be stressed that the usefulness of testing with EOAE
is limited to the evaluation of mild to moderate hearing losses.
BAEP to acoustic stimuli are used to estimate the neuro-
physiologic auditory sensitivity. They are generated on sequen-
tial levels of the auditory pathway in the brain stem. Clinical
usefulness derives from their low intra- and inter-variability
among subjects. Some BAEP studies found signiﬁcant differ-
ences and are age and gender-dependent.21 Although, BAEP
have been used in the screening of brainstem lesions in the
auditory pathway, some researchers have found abnormal
BAEP responses in cases of peripheral hearing loss.22
Although there are several studies evaluating T-EOAE in
patients with SNHL, today, we need more research to know
the usefulness of reproducibility and selective amplitude
frequencies at 0.7, 1.5, 2.2, 3.0 and 3.7 kHz of T-EOAE to
identify SNHL, because EOAE amplitude depends on
synchronicity and the functional integrity of the OHC. Thus,
the main objective of this study was to determine the useful-
ness of reproducibility and the selective frequency of T-EOAE
in patients with cochlear dysfunction. As secondary objective,
due to a previously reported relationship between T-EOAE
and BAEP in patients with SNHL, we searched for the force
of correlations between variables of both tests in our group
of patients.232. Materials and methods
2.1. Subjects
We studied 50 subjects (16 males and 34 females) who pre-
sented sequentially for consultation at a tertiary-healthcare
institution for hearing impairment in Mexico City during a
period of one year by means of T-EOAE and BAEP studies.
Control subjects (n= 6) had to be healthy individuals with-
out a cold at the time of evaluation or a negative history for
ear surgeries. The eardrum must appear as a light-gray coloror a shiny pearly-white; light should reﬂect off the eardrum
surface in the otoscopic examination without visible pathol-
ogy. Tympanometry results needed to fall within the following
standard limits: middle ear pressure between 100 and
+50 daPa, and compliance between 0.3 and 1.5 ml. All audio-
metric thresholds within the 250–8 kHz range were required to
be 625 dB HL (Hearing level). Retro-cochlear disorders were
excluded by clinical history, Cranial tomography (CT) (when
appropriate), and by BAEP evaluations to compare their re-
sults with those of the group of patients.
Patients (n= 44) were selected to cover a range of SNHL
from mild to moderate severity due to several etiologies (e.g.,
congenital deafness, ototoxic drug use, Meniere’s disease,
high-level noise exposure, presbycusis). Patient ages were be-
tween 44.06 ± 9.82 years. Twenty-four patients had a bilateral
SNHL, and twenty subjects had unilateral SNHL, all mainly in
high frequencies. Retro-cochlear pathology was excluded by
the same procedures utilized in control subjects.
Observations were carried-out in accordance with Declara-
tion of Helsinki guidelines. This study was approved by the
Institute’s Research Committee with the number: NIR-112-
2005, and informed consent was obtained from all subjects.
2.2. T-EOAE
T-EOAE were recorded in a soundproof room employing
ILO88 equipment (Otodynamics, Ltd., UK). Stimuli were
80 ls non-linear, unﬁltered rarefaction clicks provided by de-
fault protocol. Stimulus waveform intensity was expressed in
decibel peak Sound pressure level (SPL) measured in the exter-
nal ear canal at 80 dB SPL at 16 clicks/s of repetition rate. The
probe (Otodynamics, Ltd., UK) was sealed in each of the
external ear channels. T-EOAE were analyzed during the
20 ms following stimulation onset, averaging 260 responses
in each recording session. Pass criteria were reproducibility
>50% and signal–noise ratio >3 dB in four of ﬁve frequency
bands (1, 1.5, 2.2, 3 and 4 kHz).
2.3. BAEP
Each subject was tested with BAEP using aNeuropack (Nihon–
Koden, Japan) evoked potential recorder computer during
physiological sleep. The test was performed in individuals within
a sound proof room. Three standard electroencephalography
(EEG) electrodes were attached to the scalp, the negative elec-
trode on the ipsilateral mastoid, the positive on the vertex,
and the neutral electrode on the contralateralmastoid. Interelec-
trode impedance was always62 KX. Electrical activity between
the vertex and the mastoid ipsilateral to stimulation was ampli-
ﬁed 1 · 10 5 and averaged over a time base of 10 ms. Band pass
ﬁlters were set between 100 and 3000 Hz. The stimulus consisted
of 100 ls bipolar clicks administrated monaurally through
TDH-49 earphones (Telephonics, USA) at a rate of 20/s. For-
mer presentation intensity was 70 dB HL and decreased in
20 dB steps downward until the isoelectric line was reached;
then, stimuli were increased in 10 dB steps to ﬁnd the neuro-
physiological threshold. Contralateral ear masks with white
noise at 30 dB below stimulus intensity were simultaneously
administered to eliminate crossover responses, 24 following sug-
gestions of international standards.25 Stimuli average was 2024
clicks and this process was repeated at least once to ensure re-
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ing EEG signals with amplitudes >20 lV from baseline that
were cut-out from the averaging process. Latencies of waves I,
III and V were measured by a manual cursor placement at the
left and right ear recordings separately, and I–III, III–V and
I–V inter-wave intervals were calculated off-line.
2.4. Data analysis
We calculated data from T-EOAE and BAEP averaged from
right and left response in control subjects (n= 6). For compar-
ison purposes we used averages from both ears (n= 12 healthy
ears). In subjects with bilateral SNHL, we used average data
from both ears (24 patients = 48 ears with SNHL), while in
subjects with unilateral SNHL (20 patients = 20 ears with
SNHL) we utilized data only from damaged ear (n= 68 ears
with SNHL). Quantitative variables included: reproducibility
percentage; sound pressure level amplitude, and signal/noise
ratio at 0.7, 1.5, 2.2, 3.0 and 3.7 kHz of T-EOAE, and BAEP
thresholds; latencies of waves I, III, V; and latencies of intervals
I–III, III–V, I–V of BAEP response. We calculated mean and
Standard deviation (SD) of each variable and were compared
by Student’s t test. Amplitude comparison of T-EOAE and
BAEP responses in Controls and subjects with SNHL was car-
ried-out by means of X2 analysis. Afterward, we performed
Pearson’s correlation analyses between BEAP and T-EOAE
parameters; alpha value a- priori was set at 60.05.
2.5. Theory/calculation
Our work hypothesis was based on the premise that T-EOAE
amplitudes of each selective frequency are proportional to theTable 1 Comparison of T-EOAE selective frequency amplitudes (d
Frequency (kHz) Control (x, SD)
Amplitude
Signal/noise ratio
0.7 116.0 ± 13.26
8.90 ± 8.14
1.5 125.33 ± 6.53
13.70 ± 8.82
2.2 122.33 ± 7.73
16.70 ± 8.01
3.0 117.16 ± 15.65
16.42 ± 8.39
3.7 101.33 ± 36.62
17.10 ± 6.18
n.s. = not signiﬁcant.
Table 2 Latencies of main waves and interval interwaves of Brains
with SNHL.
Group Wave I (ms) Wave III (ms) Wave V (m
Control Right 1.49 ± 0.16 3.74 ± 0.21 5.52 ± 0.20
Left 1.43 ± 0.49 3.92 ± 0.28 5.48 ± 0.28
SNHL Right 1.70 ± 0.23 3.89 ± 0.40 5.78 ± 0.48
Left 1.57 ± 0.21 3.78 ± 0.24 5.72 ± 0.27
p n.s. n.s. n.s.
ms = milliseconds, n.s. = not signiﬁcant.total number of residual active sites in the organ of Corti, i.e.,
to the total length of active basilar membrane. According to
our data, it was shown that this type accounts for the effects
disclosed by statistical analysis and ﬁts the experimental data.
It can be applied in the future for quantitative cochlear analy-
ses predicting patient’s residual activity.
3. Results
3.1. General data
Median of age in the control group was 40 years of age (range:
37–42), and in SNHL group was 46 years of age (range: 22–
61). All CT in control and SNHL subjects revealed normal re-
sults. T-EOAE had a reproducibility in the control group of
91.83 ± 6.24% and in the SNHL group, 52.75 ± 30.68%
(t= 6.60, p< 0.001).
3.2. T-EOAE
T-EOAE response amplitudes and signal/noise ratio at 0.7,
1.5, 2.2, 3.0 and 3.7 kHz are presented in Table 1. All ampli-
tudes showed signiﬁcant differences among groups, with
amplitudes two times greater when comparing the control with
the SNHL group. Comparison of difference in amplitude be-
tween Controls and subjects with SNHL was statistically sig-
niﬁcant (X2 = 44.95, p< 0.05).
3.3. BAEP
Threshold average in BAEP response in the control group was
30.0 ± 0.0 dB, while the SNHL group yields an average BAEPB) and signal/noise ratio between control and SNHL groups.
SNHL (x, SD) t (p)
Amplitude Amplitude
Signal/noise ratio Signal/noise ratio
58.56 ± 37.29 7.22 (<0.001)
7.60 ± 6.64 n.s.
70.56 ± 43.46 7.51 (<0.001)
12.65 ± 6.38 n.s.
57.53 ± 41.55 8.97 (<0.001)
15.50 ± 5.39 n.s.
56.63 ± 42.16 6.59 (<0.001)
15.40 ± 8.46 n.s.
49.31 ± 37.19 3.24 (0.015)
15.70 ± 8.86 n.s.
tem auditory evoked potentials (BAEP) in controls and subjects
s) Interval I-III (ms) Interval III-V (ms) Interval I-V (ms)
2.24 ± 0.12 1.82 ± 0.11 4.10 ± 0.14
2.29 ± 0.18 1.89 ± 0.14 4.19 ± 0.19
2.18 ± 0.27 1.88 ± 0.34 4.10 ± 0.37
2.21 ± 0.20 1.85 ± 0.15 4.06 ± 0.22
n.s. n.s. n.s.
Table 3 Pearson’s correlation analyses between BEAP thresh-
old and speciﬁc frequency T-EAOE parameters.
Frequency 0.7 kHz 1.5 kHz 2.2 kHz 3.0 kHz 3.7 kHz
r 0.357 0.619 0.574 0.543 0.473
p 0.02 <0.001 <0.001 <0.001 0.002
n 42 42 42 42 42
r= correlation coefﬁcient, p= probability, n= number of cases.
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p< 0.001), audiometric syntheses (arithmetic mean of thresh-
old at 500, 1,000 and 2,000 Hz frequencies) threshold average
in SNHL group was 45.32 ± 21.18 dB HL. Because we ob-
tained a better wave V morphology at 100 dB in BAEP studies
in the SNHL group, we compared wave V between groups of
study at this intensity. Data from latencies of the main waves
and inter-wave intervals are presented in Table 2 and were also
compared. No signiﬁcant difference was observed in both mea-
surements. Comparison of difference in BAEP amplitude be-
tween Controls and subjects with SNHL was statistically
signiﬁcant (X2 = 44.95, p< 0.05).
3.4. Correlation analyses
Correlation analyses yielded negative signiﬁcance values be-
tween BAEP threshold and T-EOAE reproducibility
(0.576,<0.001) in all speciﬁc frequency values (see Table 3).
4. Discussion
4.1. Main ﬁndings
Signiﬁcant differences in T-EOAE reproducibility and selective
frequency analyses between control and SNHL groups were
disclosed in this study. These results conﬁrm the clinical useful-
ness of T-EOAE for SNHL identiﬁcation and are in agreement
with many research works in the same line.23,26–31 Frequency
selectivity-analyses usefulness in T-EOAE contained in the de-
fault report was utilized, and to our knowledge this fact is re-
ported here for the ﬁrst time. On the other hand, BAEP
threshold, T-EOAE reproducibility, and the amplitudes of all
speciﬁc frequencies showed a signiﬁcant correlation, suggesting
that BAEP threshold determination aids in the same direction
as T-EOAE in the search for SNHL and both studies are
complementary.
4.2. Results explanation
Potential relationships between T-EOAE and tuning mecha-
nisms that apparently involve only a small number of OHC,
demand another investigation.5 Peripheral damage-related
hearing loss is associated with cochlear OHC damage or loss
and some retrograde degeneration of auditory nerve ﬁbers.
Surviving auditory nerve ﬁbers in the impaired region present
elevated and broadened frequency tuning, and thus the coch-
leo-topic representation of broad-band stimuli such as speech
is distorted.27 In impaired cortical regions, increased tuning
to frequencies near the edge of the hearing loss coupled withincreased spontaneous and synchronous ﬁring was also
viewed.32
The T-EOAE threshold is only sensitive to already impor-
tant cochlear changes and this boundary does not afford a
follow-up of early-stage of cochlear dysfunction. Several
researchers have used the method of amplitude analysis of
the T-EOAE. Rahko et al. (1997), performed an analysis
with the Matlab 4.2 system with a ﬁlter bank that provides
graphically created 2D and 3D views of responses in the fre-
quency, time and amplitude coordinates. The T-EOAE were
normally modeled as the sum of many waveforms.33 Guo
et al. (1999), found from the comprehensive analysis of spec-
trum, response amplitude and reproducibility, that these
variables can be used as main sensitive parameters of T-
EOAE to evaluate whether or not is a normal-hearing.34
Jedrzejczak et al. (2009), studied several functions to incor-
porate new T-EOAE waveform analysis; the matching pur-
suit functions of waveforms were described by ﬁve
parameters, namely: frequency, latency, time span, ampli-
tude, phase, and asymmetry.35 These results from other re-
search groups support partially the use of amplitude
analysis, that we conducted here in our study.
On the other hand, we found a great overlap between nor-
mal and impaired distributions of the signal/noise ratio. Com-
parison of signal/noise ratio in Controls and subjects with
SNHL was not statistically signiﬁcant. This fact suggests that
signal/noise ratio measurements are not a signiﬁcant variable
to identify subjects with SNHL. However, other researchers
found results in the contrary direction.36 Thus, we must be
careful to ensure this statement ﬁrmly. More research is needed
to answer this question.
BAEP threshold showed a good correlation with each selec-
tive T-EAOE frequency, although BAEP responses are
obtained with a broad band stimuli, such as a click, several re-
searches showed that the major energy of click is in the 2000–
4000 Hz frequency region.37 This perhaps helps us to under-
stand why there were better correlations between BAEP
parameters and responses of T-EOAE at 1500, 2000 and
3000 Hz in subjects with SNHL,38 and complete the second
objective of this paper. Regarding analysis between the two
test parameters (BAEP and T-EOAE reproducibility percent-
age), it was interesting to see that the data were complemen-
tary. Higher the BAEP threshold, lower is the percentage of
repeatability of T-EOAE. This result is in line with several
observations from other researchers, such as those observed
in neonates.39 Recently, the T-EOAE and BAEP relationship
has been investigated. Brief tones of 1.0 and 8.0 kHz were used
to produce BAEP, and the differences between the wave-V
latencies for those two frequencies were used as a proxy for co-
chlear length. The proxy values for length were compared with
various measures of OAE obtained from the same ears.
Although, correlations were low, were signiﬁcant, suggesting
that cochlear length measured by this proxy at least, is related
to the various group and individual differences that exist in
OAE.40 Thus, T-EOAE and BAEP are robust tools for hearing
examination of patients with SNHL.
Clinical implications are promising. Our data suggest that
clinicians must be alert to T-EOAE reproducibility percentage
when they studied subjects with mild to moderate SNHL,
because the test yields comparable results to BAEP. We sug-
gest that in future, research in T-EOAE focus on parameters
Transient evoked otoacoustic emissions and cochlear dysfunction 199useful for early detection of SNHL, 36 such as data presented
here.
4.3. Limitations of the study
However, our study has some limitations, i.e. the low number
of subjects studied and thus our data must be considered as a
tendency and not as strong conclusions. In the other hand, the
cross-sectional study design employed instead of a prospective
follow-up limits the power of our results. In further studies we
will use longitudinal observations with signiﬁcant more obser-
vations in patients with SNHL.5. Conclusions
In conclusion, our data support the usefulness of reproducibil-
ity of selective amplitude frequencies at 0.7, 1.5, 2.2, 3.0 and
3.7 kHz of T-EOAE to identify SNHL, and the help of BAEP
parameters combined with T-EOAE in the evaluation of pa-
tients with SNHL. Further study will be necessary to examine
closely in more patients these correlations and their clinical use
in the patients with SNHL.References
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